Abstract
This study investigates the varied expression of DNA methyltransferase (DNMT) proteins in gastric cancer (GC) and their relationship with the biological behavior of the tissues. Immunohistochemistry was used to detect the expression of the 3 DNMTs in gastric tissues. We discovered that the positive rates of DNMT1, DNMT3a, and DNMT3b expression in GC tissues were 81.6%, 81.6%, and 68.4%, respectively, and they were significantly higher than those of both para-cancerous (39.5%, 50%, and 44.7%) and normal tissues (10.5%, 10.5%, and 7.9%). DNMT1 was well distributed in the cytoplasm and nuclei of tumor cells or glands, while DNMT3a and 3b were well distributed only in the cytoplasm, as shown by staining a dark brown color. A significant correlation between the DNMT1 and DNMT3a proteins (P < 0.01), a low correlation between DNMT3a and DNMT3b (P < 0.05), and no correlation between DNMT1 and DNMT3b (P > 0.05) were observed. DNMT1 protein expression exhibited no correlation with age, lymphnode metastasis, and also tumor differentiation, but it may have had a correlation with gender. The DNMT3 family was not associated with these factors. Therefore, DNMT overexpression is involved in gastric tumorigenesis, but there is no correlation between the DNMTs and the biological behaviors of tissues.
Similar content being viewed by others
References
He QY, Cheung YH, Leung SY, Yuen ST, Chu KM, Chiu JF (2004) Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 4:3276–3287
Yoshihara T, Kadota Y, Yoshimura Y, Tatano Y, Takeuchi N, Okitsu H, Umemoto A, Yamauchi T, Itoh K (2006) Proteomic alteration in gastric adenocarcinomas from Japanese patients. Mol Cancer 25(5):75
Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R, Malekzadeh R (2007) Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med 10(1):32–37
Pilco P, Payet E, Caceres E (2006) Gastric cancer in Lima. Rev Gastroenterol Peru 26(4):377–385
Suwanrungruang K, Wiangnon S, Sriamporn S, Sookprasert A, Rangsrikajee D, Kamsa-Ard S, Horsith S, Usantia P (2006) Trends in incidences of stomach and colorectal cancer in Khon Kaen, Thailand 1985–2004. Asian Pac J Cancer Prev 7(4):623–626
Volate SR, Davenport DM, Muga SJ, Wargovich MJ (2005) Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26:1450–1456
De Stefani E, Correa P, Boffetta P, Ronco A, Brennan P, Deneo-Pellegrini H, Mendilaharsu M (2001) Plant foods and risk of gastric cancer: a case–control study in Uruguay. Eur J Cancer Prev 10:357–364
Lynn A, Collins A, Fuller Z, Hillman K, Ratcliffe B (2006) Cruciferous vegetables and colo-rectal cancer. Proc Nutr Soc 65:135–144
Penner R, Fedorak RN, Madsen KL (2005) Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol 5:596–603
Davis CD, Hord NG (2005) Nutritional “omics” technologies for elucidating the role(s) of bioactive food components in colon cancer prevention. J Nutr 135:2694–2697
Karcz W, Gluszek S, Kot M, Matykiewicz J (2006) Influence of nutritional treatment on the postoperative course in patients with gastric cancer. Adv Med Sci 51:278–282
Yasui W, Sentani K, Motoshita J, Nakayama H (2006) Molecular pathobiology of gastric cancer. Scand J Surg 95(4):225–231
Peng DF, Kanai Y, Sawada M (2005) Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci 96(7):403–408
Saito Y, Kanai Y, Nakagawa T (2003) Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 105(4):527–532
Fang JY, Lu R, Mikovits JA, Cheng ZH, Zhu HY, Chen YX (2006) Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1. Cancer Lett 233(1):124–130
Fang JY, Xiao SD (2001) Alteration of DNA methylation in gastrointestinal carcinogenesis. J Gastroenterol Hepatol 16(9):960–968
Bheemanaik S, Reddy YV, Rao DN (2006) Structure, function and mechanism of exocyclic DNA methyltransferases. Biochem J 399(2):177–190
Shen Y, Chow J, Wang Z, Fan G (2006) Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum Mol Genet 15(17):2623–2635
Araujo FD, Croteau S, Slack AD (2001) The DNMT1 target recognition domain resides in the N terminus. J Biol Chem 276:6930–6936
Geiman TM, Sankpal UT, Robertson AK (2004) Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. Nucleic Acids Res 32(9):2716–2729
Fang JY, Cheng ZH, Chen YX, Lu R, Yang L, Zhu HY, Lu LG (2004) Expression of DNMT1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. World J Gastroenterol 10(23):3394–3398
Luczak MW, Jagodzinski PP (2006) The role of DNA methylation in cancer development. Folia Histochem Cytobiol 44(3):143–154
Zhang LL, Wu JX (2006) DNA methylation: an epigenetic mechanism for tumorigenesis. Yi Chuan 28(7):880–885
Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225–3229
Hermann A, Gowher H, Jeltsch A (2004) Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 61:2571–2587
Watanabe D, Uchiyama K, Hanaoka K (2006) Transition of mouse de novo methyltransferases expression from DNMT3b to DNMT3a during neural progenitor cell development. Neuroscience 142(3):727–737
Robertson KD, Keyomarsi K, Gonzales FA, Velicescu M, Jones PA (2000) Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G0/G1 to S phase transition in normal and tumor cells. Nucleic Acids Res 28(10):2108–2113
Yamada Y, Jackson-Grusby L, Linhart H (2005) Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA 102(38):13580–13585
Vallbohmer D, Brabender J, Yang D (2006) DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value. Clin Lung Cancer 8(1):39–44
Tian Z, Zhang ZY, Li L, Li J (2006) Expression of DNA methyltransferases in salivary adenoid cystic carcinoma and its association with the CpG islands methylation of tumor suppressor genes. Zhonghua Kou Qiang Yi Xue Za Zhi 41(7):411–415
Patra SK, Patra A, Zhao H, Dahiya R (2002) DNA methyltransferase and demethylase in human prostate cancer. Mol Carcinog 33(3):163–171
Zhu Y-M, Huang Q, LinJ, Hu Y (2006) Expression of human DNA methyltransferase 1 in colorectal cancer tissues and their corresponding distant normal tissues. Int J Colorectal Dis 22:661–666
Nakagawa T, Kanai Y, Saito Y, Kitamura T, Kakizoe T, Hirohashi S (2003) Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder. J Urol 170:2463–2466
Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S (2001) DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 91:205–212
Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H (2001) Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97:1172–1179
Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S (2001) Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 33:561–568
Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y (2002) The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Oncogene 21:4822–4829
Lin RK, Hsu HS, Chang JW (2007) Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer. Lung Cancer 55(2):205–213
Girault I, Tozlu S, Lidereau R, Bièche I (2003) Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 9:4415–4422
Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M (2005) Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 164:689–699
Acknowledgements
This work was supported by grants from the Major State Basic Research Development Program of China (973 Program) (No. 2005CB522400), the Shanghai Leading Academic Discipline Project (No.Y0205) and the Shanghai Municipal Commission for Science and Technology (No.04DZ14006) to FJY (Jing-Yuan Fang).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ding, WJ., Fang, JY., Chen, XY. et al. The Expression and Clinical Significance of DNA Methyltransferase Proteins in Human Gastric Cancer. Dig Dis Sci 53, 2083–2089 (2008). https://doi.org/10.1007/s10620-007-0145-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-007-0145-2